Bilateral infiltrative orbital disease: is it chemically induced?
Hegde
Vijay
V
Mitry
Danny
D
Snead
David
D
Ahluwalia
Harpreet
H
D000368:Aged; D001249:Asthma / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D005094:Exophthalmos / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D007839:Functional Laterality; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009784:Occupational Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D016273:Occupational Exposure / Q000009:adverse effects*; D000857:Olfaction Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D009916:Orbital Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D009943:Organophosphorus Compounds / Q000009:adverse effects; D011239:Prednisolone / Q000627:therapeutic use; D019310:Pseudolymphoma / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D013447:Sulfites / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed; D014881:Water Supply
D005938:Glucocorticoids; D009943:Organophosphorus Compounds; D013447:Sulfites; C041182:(nitrilotris(methylene))triphosphonic acid; C005200:sodium metabisulfite; D011239:Prednisolone; C025026:sodium sulfite